Esophageal CA Not Often Cause of Death in Barrett Esophagus
Among patients with Barrett’s esophagus who die within 10 years of diagnosis, approximately 2% of deaths are caused by esophageal cancer.
Diagnosis & Disease Information
Sorafenib Improves Progression-free Survival in Radioactive Iodine-refractory Metastatic Differentiated Thyroid Cancer
Sorafenib represents a potential new treatment option for patients with locally advanced or metastatic RAI-refractory differentiated thyroid cancer, according to research presented at ASCO 2013.
Patients with HPV-Positive OPSCC Demonstrate Response to Induction Chemo + Low-Dose RT + Cetuximab
Patients with HPV-associated resectable SCC of the oropharynx responded to induction chemo with paclitaxel, cisplatin, and cetuximab followed by low-dose radiation with cetuximab with minimal toxicities, found data presented at ASCO 2013.
Proton Beam Therapy with Intra-arterial Infusion Chemotherapy Safe, Effective for Locally Advanced Tongue Cancer
When combined with selective IACT, proton beam therapy appears to be as safe and effective as surgery in treating locally advanced tongue cancer, found research presented at ASCO 2013.
Frequent Heartburn Associated with Cancer of Pharynx and Larynx
Frequent heartburn is associated with a higher risk of cancers of the pharynx and larynx, which may be reduced by the use of antacids.
Lymphoseek: A New “Gold Standard” for Identifying Positive Lymph Nodes?
Lymphoseek has now demonstrated significant efficacy in diagnosis and staging of squamous cell carcinoma of the head and neck.
Racial Disparities Seen in Medicaid Patients with Head and Neck Cancers
Among Medicaid beneficiaries diagnosed with head and neck cancer, considerable racial disparities exist in treatment patterns and survival.
Two Phase 3 Trials Cast Doubts on Advantage of Induction Therapy for Head and Neck Cancer
A definitive picture of the value of induction chemotherapy for head and neck cancer remains elusive.
Identifying Molecular Subtypes of Head and Neck Cancer May Lead to Effective Preventive Treatment
New research has enhanced the understanding of the molecular profile of head and neck squamous cell carcinoma and may point the way to preventive treatment.
HPV-Associated Oropharyngeal Cancer: A Growing Dilemma
The incidence of HPV-negative oropharyngeal cancers (OPC) is in decline, but rates of HPV-positive OPC are increasing with no sign of abating.
- Loading...
Loading...
Next post in Head and Neck Cancer
Loading... 
Loading...